Literature DB >> 25999614

Pastoral care of patients with Ebola Virus Disease: A medical and canonical opinion about pastoral visits to patients with contagious and highly fatal diseases.

Stephen E Hannan1, Benedict T Nguyen2.   

Abstract

The Ebola Virus Disease is a contagious and highly fatal illness that up until recently had been geographically limited to remote areas of Africa. In 2014, Ebola patients have been transported to the United States for care or have been newly diagnosed in the United States. With the intensive medical care and isolation policies usually needed by these patients, we inquired whether pastoral care would be possible. Using clinical and canonical considerations, we analyzed the permissibility and logistical challenges pastoral care presents to the priests and lay ministers, as well as the healthcare system. We conclude that with the approval of local, state, and federal health officials, pastoral care, including provision of the sacraments, is possible. It would require proper training, proper equipment and policies, and a significant commitment of time. While the risk to the pastoral team is difficult to define, it seems low in an Ebola-capable medical system. These risks to priests and ministers seem reasonable given the inestimable benefits of receiving the sacraments during critical illness. Lay summary: Traditional pastoral visits to hospitalized patients might prove difficult or impossible for diseases that are contagious and highly fatal. This inquiry examines the feasibility, challenges, and logistical solutions to these visits. With input from bishops, priests, a canon lawyer, an epidemiologist, a physician, the CDC, and others, we conclude that pastoral visits are possible. Visits will require permission of health authorities, commitments of time, training, and a small but significant risk to the health of priests and others who volunteer for this ministry.

Entities:  

Keywords:  Confession; EVD; Ebola; Funerals; Holy Communion; Holy Eucharist; Infection Control; Pastoral Care; Personal Protective Equipment; Reconciliation; Sacrament of the Anointing of the Sick

Year:  2015        PMID: 25999614      PMCID: PMC4434790          DOI: 10.1179/0024363915Z.000000000125

Source DB:  PubMed          Journal:  Linacre Q        ISSN: 0024-3639


  2 in total

1.  Ebola vaccine--an urgent international priority.

Authors:  Rupa Kanapathipillai; Ana Maria Henao Restrepo; Patricia Fast; David Wood; Christopher Dye; Marie-Paule Kieny; Vasee Moorthy
Journal:  N Engl J Med       Date:  2014-10-07       Impact factor: 91.245

2.  Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections.

Authors:  Bruce Aylward; Philippe Barboza; Luke Bawo; Eric Bertherat; Pepe Bilivogui; Isobel Blake; Rick Brennan; Sylvie Briand; Jethro Magwati Chakauya; Kennedy Chitala; Roland M Conteh; Anne Cori; Alice Croisier; Jean-Marie Dangou; Boubacar Diallo; Christl A Donnelly; Christopher Dye; Tim Eckmanns; Neil M Ferguson; Pierre Formenty; Caroline Fuhrer; Keiji Fukuda; Tini Garske; Alex Gasasira; Stephen Gbanyan; Peter Graaff; Emmanuel Heleze; Amara Jambai; Thibaut Jombart; Francis Kasolo; Albert Mbule Kadiobo; Sakoba Keita; Daniel Kertesz; Moussa Koné; Chris Lane; Jered Markoff; Moses Massaquoi; Harriet Mills; John Mike Mulba; Emmanuel Musa; Joel Myhre; Abdusalam Nasidi; Eric Nilles; Pierre Nouvellet; Deo Nshimirimana; Isabelle Nuttall; Tolbert Nyenswah; Olushayo Olu; Scott Pendergast; William Perea; Jonathan Polonsky; Steven Riley; Olivier Ronveaux; Keita Sakoba; Ravi Santhana Gopala Krishnan; Mikiko Senga; Faisal Shuaib; Maria D Van Kerkhove; Rui Vaz; Niluka Wijekoon Kannangarage; Zabulon Yoti
Journal:  N Engl J Med       Date:  2014-09-22       Impact factor: 91.245

  2 in total
  1 in total

1.  Mourning and Management of the COVID-19 Health Emergency in the Priestly Community: Qualitative Research in a Region of Northern Italy Severely Affected by the Pandemic.

Authors:  Ines Testoni; Silvia Zanellato; Erika Iacona; Cristina Marogna; Paolo Cottone; Kirk Bingaman
Journal:  Front Public Health       Date:  2021-02-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.